The therapeutic effects of minocycline in methamphetamine related-neuropsychological disorders

Phase 4

• Conditions: Substance abuse.; Mental and behavioural disorders due to psychoactive substance use; F00-F99

• Registration Number: IRCT2016102630510N1
• Lead Sponsor: Vice Chancellor for Research of Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Methamphetamine users that have methamphetamine related-neuropsychological disorders and are seeking for a treatment; age more than 18; the duration of methamphetamine use is at least 1 year. Exclusion criteria: Side effects related to minocycline, relapse to methamphetamine use.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurocognitive impairment. Timepoint: time 0, 2 weeks, 1 month and 2 months after start of intervention and 2 months after finishing intevention. Method of measurement: Neuropsychological tools.

Secondary Outcome Measures

Name	Time	Method
Side effects, such as headache, nausea and. Timepoint: during the intervention and 2 months after that. Method of measurement: questionnaire or observation.